BDX - Becton Dickinson launches next-gen prefillable vaccine syringe BD Effivax

• Becton, Dickinson and Company ( NYSE: BDX ) said it launched a next-generation glass prefillable syringe (PFS) for vaccine PFS with tightened specifications for processability and contamination.
• BD Effivax is designed in collaboration with pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing, the company said in a Sept. 13 press release.
• "As biopharmaceutical companies continue to rapidly grow their vaccine pipelines, demand for PFS is accelerating across the globe – given their proven ability to facilitate faster administration, support dose sparing and reduce vaccine waste," said Eric Borin, Worldwide President of BD Pharmaceutical Systems.

For further details see: